CompletedNCT02140151
Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration
PHASE1 · PHASE2 · 108 planned enrolment
- Countries listed
- 1
- Registry update
- August 25, 2022
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
4 matching trial registrations
- Intervention Ranibizumab 0.5mg
- Topic Vision ageing
Showing 1–4 of 4. Every record below meets all the filters shown above.
CompletedNCT02302989
Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration
PHASE1 · PHASE2 · 4 planned enrolment
- Countries listed
- 1
- Registry update
- August 28, 2018
CompletedNCT01948830
Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD
PHASE3 · 650 planned enrolment
- Countries listed
- 19
- Registry update
- April 17, 2017
CompletedNCT01926977
Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration
PHASE1 · PHASE2 · 100 planned enrolment
- Countries listed
- 1
- Registry update
- March 3, 2016